The impact of the early monsoon rains in June 2025 on rural...
Technicals for GlaxoSmithKline Pharmaceuticals Limited
By MusingTheNews
2025-06-13 20:34
Overall Technical outlook
Price Summary
GlaxoSmithKline Pharmaceuticals Limited's stock tumbled -2.3% today, marking a lousy performance in the market. 2025-06-12, saw GLAXO's stock open at 3398.0, hit a peak of 3439.8, fall to a low of 3310.3, and close down -2.3% at 3320.0, with 166364 shares changing hands. For the 52-week period, the stock's highest price is 3466.2, and the lowest price is 1956.2. 4 analysts predict that the future price of GLAXO will be in the range of 2600.0 to 3500.0, with a mean expected price of about 3072.0.
Technicals
Support and Resistance: The price currently sits at 3320.0, finding support at 2906.8 and resistance at 3348.2. These levels define a range for GlaxoSmithKline Pharmaceuticals Limited where the price may move, with 2906.8 offering a base and 3348.2 limiting upward momentum. Support/Resistance for GLAXO
Aroon: The AROON is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move. Aroon chart for GlaxoSmithKline Pharmaceuticals Limited
Bol. Bands: The BOLL BANDS is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market. Bolinger Bands chart for GlaxoSmithKline Pharmaceuticals Limited
Parabolic SAR: The PSAR has moved from a bullish to a bearish position, suggesting a possible trend reversal. If this shift is confirmed by other indicators, it could be a strong bearish signal. Traders should watch for additional signs of a broader market downturn before making any decisions for GLAXO. Parabolic Stop and Reverse chart for GlaxoSmithKline Pharmaceuticals Limited
Stochastic: The STOCHASTIC is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation. Stochastic chart for GlaxoSmithKline Pharmaceuticals Limited
Tripple Moving Agerage: The alignment of the 20, 50, and 100 moving averages indicates a bearish trend for GLAXO, but the wavering slopes of the 20 and 50 SMAs suggest that this momentum may be fading. This weakening could be a precursor to a bullish reversal, as the market's current downtrend shows signs of losing steam. Investors may soon see a shift towards more positive price action as the trend begins to change. Tripple SMA chart for GlaxoSmithKline Pharmaceuticals Limited
A thorough analysis of a company involves looking beyond its stock price movements and trading patterns. You must also examine its fundamentals, which include profitability, growth prospects, and competitive advantages. Additionally, the industry in which the company operates provides important context, as factors like technological innovations, regulation, and market demand influence performance. By integrating this information with technical analysis, more accurate predictions about the company's future can be made.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
This article explores the Reserve Bank of India's initiatives aimed at enabling...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.